181 related articles for article (PubMed ID: 37550349)
1. Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array.
Chrastinová L; Pastva O; Bocková M; Kovářová H; Ceznerová E; Kotlín R; Pecherková P; Štikarová J; Hlaváčková A; Havlíček M; Válka J; Homola J; Suttnar J
Sci Rep; 2023 Aug; 13(1):12816. PubMed ID: 37550349
[TBL] [Abstract][Full Text] [Related]
2. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.
Ahn YH; Shin PM; Kim YS; Oh NR; Ji ES; Kim KH; Lee YJ; Kim SH; Yoo JS
Analyst; 2013 Nov; 138(21):6454-62. PubMed ID: 24027776
[TBL] [Abstract][Full Text] [Related]
4. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
5. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
[TBL] [Abstract][Full Text] [Related]
6. Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes.
Yanada M; Mizuno S; Yamasaki S; Harada K; Konuma T; Tamaki H; Shingai N; Uchida N; Ozawa Y; Tanaka M; Onizuka M; Sawa M; Nakamae H; Shiratori S; Matsuoka KI; Eto T; Kawakita T; Maruyama Y; Ichinohe T; Kanda Y; Atsuta Y; Aoki J; Yano S
Leuk Lymphoma; 2021 Dec; 62(14):3411-3419. PubMed ID: 34348554
[TBL] [Abstract][Full Text] [Related]
7. Roles of glycoprotein glycosylation in the pathogenesis of an endemic osteoarthritis, Kashin–Beck disease, and effectiveness evaluation of sodium hyaluronate treatment.
Wang S; Gao Z; Liu H; Meng P; Wu C; Lammi M; Guo X
Turk J Med Sci; 2020 Jun; 50(4):1028-1037. PubMed ID: 31655502
[TBL] [Abstract][Full Text] [Related]
8. Analysis of glycoproteins in cell culture supernatants using a lectin immunosensor technique.
Liljeblad M; Lundblad A; Påhlsson P
Biosens Bioelectron; 2002 Oct; 17(10):883-91. PubMed ID: 12243907
[TBL] [Abstract][Full Text] [Related]
9. Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry.
Bachas C; Duetz C; van Spronsen MF; Verhoeff J; Garcia Vallejo JJ; Jansen JH; Cloos J; Westers TM; van de Loosdrecht AA
Cytometry B Clin Cytom; 2023 Mar; 104(2):128-140. PubMed ID: 35289472
[TBL] [Abstract][Full Text] [Related]
10. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
[TBL] [Abstract][Full Text] [Related]
11. Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
Booth A; Bell T; Halhol S; Pan S; Welch V; Merinopoulou E; Lambrelli D; Cox A
J Med Internet Res; 2019 Nov; 21(11):e14285. PubMed ID: 31755871
[TBL] [Abstract][Full Text] [Related]
12. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
[TBL] [Abstract][Full Text] [Related]
13. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic syndromes.
Kota V; Ogbonnaya A; Farrelly E; Schroader BK; Raju A; Kristo F; Dalal M
Future Oncol; 2022 Nov; 18(36):4017-4029. PubMed ID: 36622291
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.
Stauder R; Lambert J; Desruol-Allardin S; Savre I; Gaugler L; Stojkov I; Siebert U; Chevrou-Séverac H
Eur J Haematol; 2020 May; 104(5):476-487. PubMed ID: 31985078
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes.
Skalska-Bugala A; Starczak M; Szukalski Ł; Gawronski M; Siomek-Gorecka A; Szpotan J; Labejszo A; Zarakowska E; Szpila A; Jachalska A; Szukalska A; Kruszewski M; Sadowska A; Wasilow A; Baginska P; Czyz J; Olinski R; Rozalski R; Gackowski D
Cells; 2022 Mar; 11(5):. PubMed ID: 35269510
[TBL] [Abstract][Full Text] [Related]
18. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
West AH; Godley LA; Churpek JE
Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H
Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
[TBL] [Abstract][Full Text] [Related]
20. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
